Tango Therapeutics TNGX reported its Q4 earnings results on Monday, March 18, 2024 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Tango Therapeutics missed estimated earnings by -14.000000000000002%, reporting an EPS of $-0.32 versus an estimate of $-0.28.
Revenue was down $980 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 6.0% drop in the share price the next day.
Here's a look at Tango Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.34 | -0.34 | -0.35 | -0.35 |
| EPS Actual | -0.23 | -0.23 | -0.32 | -0.33 |
| Revenue Estimate | 7.32M | 6.95M | 6.71M | 6.44M |
| Revenue Actual | 10.73M | 14.60M | 5.77M | 6.41M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Tango Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
